Zinc, Chromium, Vitamin C, and Copper Combination Supplement for Prediabetes Progression
A phase 2 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 670 participants.
Also called NCT04511468
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase
- Phase 2
- Enrolled
- 670 participants
- Sponsor
- Registry
-
NCT04511468
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Indonesia
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT04511468. Randomized; quadruple masking; primary purpose prevention. Start 2021-06-23 (actual); primary completion 2024-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Zinc, Chromium, Vitamin C, and Copper Combination Supplement for Prediabetes Progression
- Acronym
- CHANGE
- Condition
- PreDiabetes
- Condition
- Nutrition
- Intervention (Dietary supplement)
- Zinc, Chromium, Vitamin C, and Copper Supplementation
- Intervention (Behavioral)
- Standard healthy lifestyle intervention
- Intervention (Other)
- Placebo
- Lead sponsor
- Universitas Indonesia
- Collaborator
- Blackmores Institute
Record details
- Record id
cardio:ct-nct04511468- Content hash
245d82dcd3ef87c221176bfa2d9a48b461106367cb858f9d9c193b8ef1d5c9da